Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation

Journal of Cellular Physiology

Volumn 216, Issue 1, 2008, Pages 234-244

  Savard, Martin ^a   Barbaz, David ^a   Bélanger, Simon ^a   Müller Esterl, Werner ^b   Bkaily, Ghassan ^a   D'Orléans Juste, Pedro ^a   Coté, Jérôme ^a   Bovenzi, Veronica ^a   Gobeil Jr , Fernand ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; CALCIUM; HISTONE H3; ICATIBANT; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; R 954; RADIOLIGAND; BRADYKININ; HIGH MOLECULAR WEIGHT KININOGEN; LOW MOLECULAR WEIGHT KININOGEN; PHOSPHATIDYLINOSITOL 3 KINASE; VASODILATOR AGENT;

ACETYLATION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ASSAY; AUTORADIOGRAPHY; CALCIUM MOBILIZATION; CELL MEMBRANE; CELL NUCLEUS; CELL ORGANELLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FUNCTION TEST; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; IMMEDIATE EARLY GENE; IMMUNOGOLD LABELING; KNOCKOUT MOUSE; LIGAND BINDING; LIVER CELL; MALE; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; RADIOASSAY; SPRAGUE DAWLEY RAT;

MUS; RATTUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BRADYKININ; CELL MEMBRANE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; HEPATOCYTES; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; KININOGEN, LOW-MOLECULAR-WEIGHT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-AKT; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 44449119495     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21398     Document Type: Article

References (60)

1. Alla SA, Quitterer U, Grigoriev S, Maidhof A, Haasemann M, Jarnagin K, Muller-Esterl W. 1996. Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies. J Biol Chem 271:1748-1755.
2. Arganaraz GA, Silva JA, Jr., Perosa SR, Pessoa LG, Carvalho FF, Bascands JL, Bader M, da Silva Trindade E, Amado D, Cavalheiro EA, Pesquero JB, da Graca Naffah-Mazzacoratti M. 2004. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Brain Res 1006:114-125.
3. Bachvarov DR, Houle S, Bachvarova M, Bouthillier J, Adam A, Marceau F. 2001. Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J Pharmacol Exp Ther 297:19-26.
4. Baird JW, Nibbs RJ, Komai-Koma M, Connolly JA, Ottersbach K, Clark-Lewis I, Liew FY, Graham GJ. 1999. ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. J Biol Chem 274:33496-33503.
5. Bhattacharya M, Peri KG, Almazan G, Ribeiro-da-Silva A, Shichi H, Durocher Y, Abramovitz M, Hou X, Varma DR, Chemtob S. 1998. Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci USA 95:15792-15797.
6. Bkaily G, Nader M, Avedanian L, Choufani S, Jacques D, D'Orleans-Juste P, Gobeil F, Chemtob S, Al-Khoury J. 2006. G-protein-coupled receptors, channels, and Na+-H+ exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells. Can J Physiol Pharmacol 84:431-441.
7. Blais PA, Cote J, Morin J, Larouche A, Gendron G, Fortier A, Regoli D, Neugebauer W, Gobeil F, Jr. 2005. Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study. Peptides 26:1317-1322.
8. Blaukat A, Abd Alla S, Lohse MJ, Muller-Esterl W. 1996. Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts. J Biol Chem 271:32366-32374.
9. Blaukat A, Herzer K, Schroeder C, Bachmann M, Nash N, Muller-Esterl W. 1999. Overexpression and functional characterization of kinin receptors reveal subtype-specific phosphorylation. Biochemistry 38:1300-1309.
10. Boivin B, Lavoie C, Vaniotis G, Baragli A, Villeneuve LR, Ethier N, Trieu P, Allen BG, Hebert TE. 2006. Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardio myocytes. Cardiovasc Res 71:69-78.
11. Borkowski JA, Ransom RW, Seabrook GR, Trumbauer M, Chen H, Hill RG, Strader CD, Hess JF. 1995. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem 270:13706-13710.
12. Camargo de Andrade MC, Di Marco GS, de Paulo Castro Teixeira V, Mortara RA, Sabatini RA, Pesquero JB, Boim MA, Carmona AK, Schor N, Casarini DE. 2006. Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Renal Physiol 290:F364-F375.
13. Chavakis T, Kanse SM, Lupu F, Hammes HP, Muller-Esterl W, Pixley RA, Colman RW, Preissner KT. 2000. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood 96:514-522.
14. Chen EY, Emerich DF, Bartus RT, Kordower JH. 2000. B2 bradykinin receptor immunoreactivity in rat brain. J Comp Neurol 427:1-18.
15. Crane-Robinson C, Myers FA, Hebbes TR, Clayton AL, Thorne AW. 1999. Chromatin immunoprecipitation assays in acetylation mapping of higher eukaryotes. Methods Enzymol 304:533-547.
16. D'Santos CS, Clarke JH, Divecha N. 1998. Phospholipid signalling in the nucleus. Een DAG uit het leven van de inositide signalering in de nucleus. Biochim Biophys Acta 1436:201-232.
17. Duchene J, Schanstra JP, Pecher C, Pizard A, Susini C, Esteve JP, Bascands JL, Girolami JP. 2002. A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem 277:40375-40383.
18. Echevarria W, Leite MF, Guerra MT, Zipfel WR, Nathanson MH. 2003. Regulation of calcium signals in the nucleus by a nucleoplasms reticulum. Nat Cell Biol 5:440-446.
19. Figueroa CD, Gonzalez CB, Grigoriev S, Abd Alla SA, Haasemann M, Jarnagin K, Muller-Esterl W. 1995. Probing for the bradykinin B(2) receptor in rat kidney by anti-peptide and anti-ligand antibodies. J Histochem Cytochem 43:137-148.
20. Figueroa CD, Marchant A, Novoa U, Forstermann U, Jarnagin K, Scholkens B, Muller-Esterl W. 2001. Differential distribution of bradykinin B (2) receptor in the rat and human cardiovascular system. Hypertension 37:110-120.
21. Fricker M, Hollinshead M, White N, Vaux D. 1997. Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Biol 136:531-544.
22. Gobeil F, Jr., Charland S, Filteau C, Perron SI, Neugebauer W, Regoli D. 1999. Kinin B1 receptor antagonists containing alpha-methyl-L-phenylalanine: In vitro and in vivo antagonistic activities. Hypertension 33:823-829.
23. Gobeil F, Jr., Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, Abran D, Hou X, Beauchamp MH, Quiniou C, Bouayad A, Choufani S, Bhattacharya M, Molotchnikoff S, Ribeiro-Da-Silva A, Varma DR, Bkaily G, Chemtob S. 2002. Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ Res 90:682-689.
24. Gobeil F, Jr., Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM, Checchin D, Sennlaub F, Hou X, Nader M, Bkaily G, Ribeiro-da-Silva A, Goetzl EJ, Chemtob S. 2003. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 278:38875-38883.
25. Gobeil F, Fortier A, Zhu T, Bossolasco M, Leduc M, Grandbois M, Heveker N, Bkaily G, Chemtob S, Barbaz D. 2006a. G-protein-coupled receptors signalling at the cell nucleus: An emerging paradigm. Can J Physiol Pharmacol 84:287-297.
26. Gobeil F, Jr., Zhu T, Brault S, Geha A, Vazquez-Tello A, Fortier A, Barbaz D, Checchin D, Hou X, Nader M, Bkaily G, Gratton JP, Heveker N, Ribeiro-da-Silva A, Peri K, Bard H, Chorvatova A, D'Orleans-Juste P, Goetzl EJ, Chemtob S. 2006b. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J Biol Chem 281:16058-16067.
27. Goetzl EJ. 2007. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. FASEB J 21:638-642.
28. Haller H, Lindschau C, Quass P, Luft FC. 1999. Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10:S75-S83.
29. Houle S, Marceau F. 2003. Wortmannin alters the intracellular trafficking of the bradykinin B2 receptor: Role of phosphoinositide 3-kinase and Rab5. Biochem J 375:151-158.
30. Huang WC, Chen CC. 2005. Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25:6592-6602.
31. Isaac C, Pollard JW, Meier UT. 2001. Intranuclear endoplasmic reticulum induced by Nopp140 mimics the nucleolar channel system of human endometrium. J Cell Sci 114:4253-4264.
32. Joun H, Lanske B, Karperien M, Qian F, Defize L, Abou-Samra A. 1997. Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: A new PTH/PTHrP receptor splice variant that lacks the signal peptide. Endocrinology 138:1742-1749.
33. Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M, Zhang M, Bao G, Wang F, Zhang X, Yang R, Fan F, Chen X, Pei G, Ma L. 2005. A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription. Cell 123:833-847.
34. Kiefer P, Dickson C. 1995. Nucleolar association of fibroblast growth factor 3 via specific sequence motifs has inhibitory effects on cell growth. Mol Cell Biol 15:4364-4374.
35. Lagace TA, Ridgway ND. 2005. The rate-limiting enzyme in phosphatidylcholine synthesis regulates proliferation of the nucleoplasms reticulum. Mol Biol Cell 16:1120-1130.
36. Lamb ME, De Weerd WF, Leeb-Lundberg LM. 2001. Agonist-promoted trafficking of human bradykinin receptors: Arrestin- and dynamin-independent sequestration of the B2 receptor and bradykinin in HEK293 cells. Biochem J 355:741-750.
37. Lee DK, Lanca AJ, Cheng R, Nguyen T, Ji XD, Gobeil F, Jr., Chemtob S, George SR, O'Dowd BF. 2004. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279:7901-7908.
38. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. 2005. International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77.
39. Li XC, Carretero OA, Navar LG, Zhuo JL. 2006. AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: Role of cytoskeleton microtubules and tyrosine phosphatases. Am J Physiol Renal Physiol 291:F375-F383.
40. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3:802-808.
41. Lui PP, Lee CY, Tsang D, Kong SK, 1998. Ca2+ is released from the nuclear tubular structure into nucleoplasm in C6 glioma cells after stimulation with phorbol ester. FEBS Lett 432:82-87.
42. Malviya AN, Klein C. 2006. Mechanism regulating nuclear calcium signaling. Can J Physiol Pharmacol 84:403-422.
43. Marinova Z, Vukojevic V, Surcheva S, Yakovleva T, Cebers G, Pasikova N, Usynin I, Hugonin L, Fang W, Hallberg M, Hirschberg D, Bergman T, Langel U, Hauser KF, Pramanik A, Aldrich JV, Graslund A, Terenius L, Bakalkin G. 2005. Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission. J Biol Chem 280:26360-26370.
44. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. 1997. Opposing mitogenic anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: A critical role for nuclear targeting. Proc Natl Acad Sci USA 94:13630-13635.
45. Murone C, Perich RB, Schlawe I, Chai SY, Casley D, MacGregor DP, Muller-Esterl W, Mendelsohn FA. 1996. Characterization and localization of bradykinin B2 receptors in the guinea-pig using a radioiodinated HOE140 analogue. Eur J Pharmacol 306:237-247.
46. Neri LM, Borgatti P, Capitani S, Martelli AM. 2002. The nuclear phosphoinositide 3-kinase/AKT pathway: A new second messenger system. Biochim Biophys Acta 1584:73-80.
47. Oehlke J, Lorenz D, Wiesner B, Bienert M. 2005. Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides. J Mol Recognit 18:50-59.
48. Re R. 1999. The nature of intracrine peptide hormone action. Hypertension 34:534-538.
49. Renné T, Dedio J, David G, Muller-Esterl W. 2000. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J Biol Chem 275:33688-33696.
50. Sesti S, Martino G, Mazzulla S, Chimenti R. 2005. Effect of bradykinin on nitric oxide. production, urea synthesis and viability of rat hepatocyte cultures. BMC Physiol 5 2.
51. Simaan M, Bedard-Goulet S, Fessart D, Gratton JP, Laporte SA. 2005. Dissociation of beta-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization. Cell Signal 17:1074-1083.
52. Sun LY, D'Ercole AJ. 2006. Insulin-like growth factor-I stimulates histone H3 and H4 acetylation in the brain in vivo. Endocrinology 147:5480-5490.
53. Tahara K, Fujii K, Yamaguchi K, Suematsu T, Shiraishi N, Kitano S. 2001. Increased expression of P-cadherin mRNA in the mouse peritoneum after carbon dioxide insufflation. Surg Endosc 15:946-949.
54. van Kats JP, de Lannoy LM, Jan Danser AH, van Meegen JR, Verdouw PD, Schalekamp MA. 1997. Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension 30:42-49.
55. Vodovotz Y, Kim PK, Bagci EZ, Ermentrout GB, Chow CC, Bahar I, Billiar TR. 2004. Inflammatory modulation of hepatocyte apoptosis by nitric oxide: In vivo, in vitro, and in silico studies. Curr Mol Med 4:753-762.
56. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC. 2004. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6:251-261.
57. Weaver IC, D'Alessio AC, Brown SE, Hellstrom IC, Dymov S, Sharma S, Szyf M, Meaney MJ. 2007. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: Altering epigenetic marks by immediate-early genes. J Neurosci 27:1756-1768.
58. Willard FS, Crouch MF. 2000. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol Cell Biol 78:387-394.
59. Yaqoob M, Snell CR, Burgess GM. 1995. Carbohydrate analysis of the B2 bradykinin receptor from rat uterus. J Neurochem 65:1290-1296.
60. Zhuo JL, Li XC, Garvin JL, Navar LG, Carretero OA. 2006. Intracellular angiotensin II induces cytosolic Ca2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells. Am J Physiol Renal Physiol 290:F1382-F1390.